ArticleInternational health2025
The burden and risk factors of female genital schistosomiasis in two schistosomiasis-endemic states of Nigeria.
Article in International health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and associated risk factors of self-reported symptoms suggestive of female genital schistosomiasis (FGS) among women in KwaZulu-Natal, South Africa.PLoS neglected tropical diseases · 2026Article
- Determining spatio-temporal distribution and hotspots for female schistosomiasis in Ghana, 2020-2024: a call for increased public health action against a neglected tropical disease.Infectious diseases of poverty · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
backgroundFemale Genital Schistosomiasis (FGS) is a neglected gynaecological condition that arises from chronic complications of schistosomiasis infection. It is estimated to affect 56 million women and girls in sub-Saharan Africa. In Nigeria, the burden of FGS is largely unknown, and many cases of FGS are misdiagnosed due to poor levels of awareness among health workers.
methodsUsing a cross-sectional study design, we investigated the prevalence of FGS and its associated risk factors among reproductive-aged women in 15 schistosomiasis hotspot communities in Ondo and Kebbi States of Nigeria. A questionnaire-based survey was conducted with community members to explore their sociodemographic characteristics and reported urogenital symptoms. Urine samples were collected to investigate presence of haematuria and Schistosoma haematobium eggs. Visual examination by colposcopy was also conducted among sexually active participants to determine their FGS status.
resultsFive hundred and sixty-one (561) females were visually examined, with FGS prevalence estimated at 41.4% (95% C.I: 37.3 to 45.5). Age, marital status, educational attainment and state of residence were significantly associated (P < 0.05) with positive visual FGS diagnosis. Other factors such as surface water source, reported signs of blood in urine and presence of S. haematobium eggs in urine were associated risks for FGS.
conclusionFGS is a huge burden in schistosomiasis endemic areas of Nigeria. There is need for community-wide interventions to address and manage FGS, and integration of FGS into other sexual and reproductive health programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.